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Abstract
Purpose: Noninfectious comorbidities such as cardiovascular diseases have become increasingly prevalent and
occur earlier in life in persons with HIV infection. Despite the emerging body of literature linking environmental
exposures to chronic disease outcomes in the general population, the impacts of environmental exposures have
received little attention in HIV-infected population. The aim of this study is to investigate whether individuals living
with HIV have elevated prevalence of heavy metals compared to non-HIV infected individuals in United States.
Methods: We used the National Health and Nutrition Examination Survey (NHANES) 2003-2010 to compare
exposures to heavy metals including cadmium, lead, and total mercury in HIV infected and non-HIV infected subjects.
Results: In this cross-sectional study, we found that HIV-infected individuals had higher concentrations of all heavy
metals than the non-HIV infected group. In a multivariate linear regression model, HIV status was significantly
associated with increased blood cadmium (p=0.03) after adjusting for age, sex, race, education, poverty income ratio,
and smoking. However, HIV status was not statistically associated with lead or mercury levels after adjusting for the
same covariates.
Conclusions: Our findings suggest that HIV-infected patients might be significantly more exposed to cadmium
compared to non-HIV infected individuals which could contribute to higher prevalence of chronic diseases among
HIV-infected subjects. Further research is warranted to identify sources of exposure and to understand more about
specific health outcomes.
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Introduction
Human Immunodeficiency Virus (HIV) infection is one of the
most prevalent chronic infectious diseases, causing significant
morbidity and mortality worldwide. An estimated 1,178,350
persons aged 13 and older were living with HIV infection in
2008 in the United States (U.S.) [1], and approximately 35
million people are currently living with HIV infection worldwide
[2]. After the introduction and advancement of antiretroviral
therapy (ART), HIV infections can now be managed for years,
increasing the average life span of HIV infected individuals
tremendously [3]. From 1996 to 2005, the average life
expectancy after HIV diagnosis in the United States increased
from 10.5 to 22.5 years [4], and the annual death rates of
people with HIV have fell from 1.69% in 1999-2000 to 0.96% in
2007-2008 [5].
Together with these improvements in health outcomes for
individuals living with HIV, noninfectious comorbidities including
cardiovascular disease, hypertension, diabetes mellitus, bone
fractures, renal failure, and HIV-related malignancies have
become emerging health problems among this population
today [6]. Noninfectious comorbidities now account for more
than half of the deaths in recent years among HIV-infected
patients who took ART [7,8]. Therefore, it is important to study
the determinants of chronic diseases in this population.
Not only do HIV-infected patients have higher rates of
cardiovascular disease than the general population but these
outcomes also occur at a younger age, which could be due to
chronic inflammation related to HIV infection and the use of
antiretroviral medications [9,10]. Exposure to higher levels of
environmental pollutants such as heavy metals, which have
been reported to increase the risk of many chronic diseases in
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the general population [11–13], may explain earlier onset
and/or the excess risks of chronic disease observed in HIV-
infected individuals. Heavy metals including lead, cadmium,
and mercury are widespread environmental exposures, and
they ranked in the top 10 on the current Agency for Toxic
Substances and Disease Registry Priority List of Hazardous
Substances [14]. Exposure to cadmium could occur through
consumption of shellfish and dark, leafy vegetable and
cigarette smoking [15]. Lead exposure is totally due to
inhalation of lead dust or ingestion of lead-contaminated food
and water [16]. Mercury exposure occurs predominantly
through consumption of fish [17]. The cumulative deleterious
effects of these heavy metals can cause chronic degenerative
changes [18], leading to cardiovascular, respiratory, liver,
kidney, and nervous system diseases [19,20]. However, their
potential health effects in HIV-infected group received little
attention.
HIV-infected populations generally have a lower socio-
economic status and live in poorer communities [21], which
may consequently result in higher exposures to these toxins,
considering the correlation between area-level poverty and
environmental pollution. Moreover, HIV infection itself could
increase sensitivity to the adverse health effects of
environmental pollution because of the combination of the
effects of environmental exposures and chronic inflammation
due to HIV infection [22]. If HIV-infected patients are also at
higher risk of exposure to these environmental pollutants
compared to the general population, these exposures could
contribute to the higher rates and/or the more rapid onset of
noninfectious comorbidities among HIV-infected patients. To
our knowledge, few studies have compared the levels of
exposures to environmental heavy metals between HIV-
infected and HIV-uninfected populations.
In this study, we analyzed the data from the 2003-2010
National Health and Nutrition Examination Surveys to examine
HIV-infected patients’ exposures to three environmental
pollutants, which were measured by blood cadmium, blood
lead, and blood total mercury concentrations, compared to
individuals without HIV infection.
Methods
1.1 Study population
NHANES uses a complex, multistage sampling design to
gain nationally representative samples of the non-
institutionalized U.S. civilian population [23]. The NHANES
surveys collect data from personal interviews, examinations,
and laboratory tests of biological samples. The data have been
released for public use in two-year increments since 1999. For
NHANES 2003-2010, there were 51,838 persons selected for
the biannual samples combined, 41,156 (79.4 percent) of those
were interviewed, and 39,608 (76.4 percent) of those
underwent a physical examination in a Mobile Examination
Center (MEC) [24].
Blood cadmium, blood lead, and blood total mercury
concentrations were measured simultaneously in a subsample
(n=37,761) of persons 1 year and older in each biannual
sample from 2003 to 2010. HIV antibody tests were done in a
subsample (n=13,605) of persons 18 years old to 49 years old
in the 2003-2008 data cycles and 18 years old to 59 years old
in the 2009-2010 data cycle. For the present analysis, we
selected all participants aged 18 to 49 years old who had HIV
antibody tests and blood cadmium, lead and mercury tests
during these four data cycles as the study population.
Therefore, a total of 11,761 eligible participants were examined
in this cross-sectional study.
Because each NHANES data cycle subsample was
representative of the total population, the appropriate weight
was calculated for the combined subsamples after considering
the additional stage of sampling, the unequal probability of
selection and the non-response rate [23].
1.2 Blood cadmium, lead and total mercury
measurements
The laboratory procedure and quality control of blood
cadmium, lead and total mercury concentrations are described
in detail in the NHANES Laboratory/Medical Technologist
Procedures Manual (LPM) [23]. Briefly, whole blood specimens
were processed, frozen and then shipped to National Center
for Environmental Health for testing. Blood cadmium, lead, and
total mercury concentrations were measured by inductively
coupled plasma mass spectrometry, based on quadrupole ICP-
MS technology [25]. The coefficient of variations (CVs) range
from 2.9%–11.3% for cadmium, 1.2%-4.4 for lead, and
2.3%-41.2% for total mercury through the study period.
The detection limit for cadmium, lead, and mercury in blood
specimens are based on three times the standard deviation of
blood blank run for a minimum of 20 runs [25]. The limit of
detection of cadmium was 0.20µg/L throughout all data cycles.
The limit of detection of lead was 0.3µg/dL (2003-2004 data
cycles) and 0.25µg/dL (2005-2010 data cycles). The limit of
detection of blood total mercury was 0.20ug/L (2003-2006 data
cycle), 0.28µg/L (2007-2008 data cycles), and 0.33µg/L
(2009-2010 data cycle). As recommended by the NHANES,
when the result was below the limit of detection, the value for
that variable is the detection limit divided by the square root of
two.
1.3 HIV antibody test
As described detail in the NHANES LPM, blood specimens
were processed, stored, and shipped to National Centers for
Disease Control and Prevention [23]. All blood samples were
tested using enzyme immunoassay (EIA) to detect antibody to
human immunodeficiency virus type 1 or type 2 (Bio-Rad
Laboratories, Hercules, CA). Positive EIA samples were
retested with the same assay and repeatedly reactive samples
were then tested by HIV-1 Western Blot (Calypte Biomedical
Corporation, Rockville, MD). Based on the EIA and Western
Blot results, samples were classified as HIV antibody positive,
negative or indeterminant according to different patterns
presented [26]. Subjects with positive HIV antibody test results
were categorized as an HIV case, while those with negative
results were categorized as a non-HIV case. Subjects with
indeterminant HIV antibody test results were excluded from this
study.
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1.4 Serum cotinine measurements
Serum cotinine, which is a major metabolite of nicotine and
has a half-life about 15-20 hours [27,28], was measured by the
ID HPLC-APCI MS/MS method as described in the NHANES
LPM in the combined subsample (n=35,232) of persons 3
years and older in each cycle from 2003–2010 [23]. Cotinine
concentrations were derived from the ratio of native to labeled
cotinine in the sample by comparisons to a standard curve. The
limit of detection of serum cotinine was 0.015ng/mL throughout
the study period. In cases, where the result was below the limit
of detection, the value for that variable is the detection limit
divided by the square root of two (i.e. 0.011ng/mL).
1.5 Other Covariates
Several covariates and potential confounders were included
in this study. Age (18–49), gender, race/ethnicity (categorized
as Non-Hispanic white, Non-Hispanic black, or others), and
educational levels (categorized as less than high school, high
school, or more than high school) were obtained by self-
reported questionnaire. NHANES also calculated a poverty-to-
income ratio (PIR). It was categorized as less than 1.0, 1.0-2.0,
or more than 2.0 with the values < 1.00 as below the official
poverty threshold [29]. Pack-year was calculated by multiplying
the number of packs of cigarettes smoked per day by the
number of years the person has smoked (i.e. 1 pack=20
cigarettes). All information on tobacco use was collected using
self-reported questionnaires.
1.6 Statistical analysis
Descriptive statistics such as two-sided Student t-tests and
Wald chi-square analysis were performed, where appropriate,
after considering the complex sampling strategy. Results from
all three heavy metals were log transformed to allow a
comparison by the HIV antibody status. Multivariate linear
regression models were used to evaluate the associations
between HIV status and each heavy metal. We firstly used a
model adjusting for covariates including age, sex, race/
ethnicity, education, poverty income ratio, and serum cotinine,
and a second model which additionally adjusted for pack-years,
was also used. Since the outcome, heavy metals, were log-
transformed in the analyses, we used exponential function of
the point estimates obtained from the models for interpretations
(i.e. the point estimate = log (Heavy metals for HIV-infected) –
log (Heavy metal for non-HIV infected)). The sample weights,
stratification and clustering design variables were also
incorporated into all SAS survey procedures to ensure the
correct estimation of sampling error. An 8-year MEC
subsample weight was calculated for the combined 2003-2010
data by following the NHANES analytic and reporting
guidelines and by assigning one-fourth of each 2-year MEC
subsample weight 2003 to 2010 data cycles [30]. This
calculated weight was used to analyze the combined NHANES
2003-2010 data. All statistical analyses were performed using
SAS 9.3 survey procedures software (SAS Institute Inc., Cary,
NC).
The protocol of NHANES has been approved by the Center
for Disease Control and Prevention National Center of Health
Statistics Research Ethics Review Board and this analysis was
approved by the Institutional Review Board at the University of
Florida.
Results
Among 11,761 participants, 60 were HIV-infected subjects
from the 2003-2010 NHANES data. Table 1 presents the
geometric means of blood heavy metals according to HIV
antibody status. Subjects with HIV had significantly higher
levels of blood cadmium (0.47 vs. 0.33 ug/l, p=0.005) and lead
(1.43 vs. 1.11 ug/l, p=0.016) compared to those without HIV. In
addition, HIV-infected individuals had higher but not statistically
significant different levels of total mercury (1.04 vs. 0.91 ug/l,
p= 0.5) than HIV-uninfected population.
Table 2 presents the distribution of demographic and
socioeconomic status by HIV status. Subjects with HIV
infection were more likely to be male, older, non-Hispanic
Black, and with lower PIR (all p<0.05). No significant
differences in education were observed between HIV-infected
persons and those without HIV infection.
Table 3 shows the comparison of geometric means of blood
heavy metals by age, gender, race/ethnicity, PIR, and
education in subjects with HIV and without HIV. HIV-infected
patients whose PIR were <1.00 had significantly higher levels
of blood cadmium, lead, and total mercury than non-HIV
positive subjects in the same PIR group. In addition, female
subjects with HIV infection had higher levels of blood cadmium
and lead compared to those females without HIV. Besides,
HIV-infected subjects who were male or who were aged from
35 to 49 years old had higher level of blood cadmium than
those without HIV. Moreover, HIV-infected patients who were
aged from 18 to 34 years old, who reported being neither non-
Hispanic white or black, or who had only graduated from high
Table 1. Difference of Geometric Means of Blood Heavy
Metal Concentration by HIV Status among US Adults
(n=11761).
Heavy
Metals HIV Non-HIV
p-
valueb
 N <LODa
Weighted
Geometric
Mean
(95%CI) N <LODa
Weighted
Geometric
Mean
(95%CI)  
Blood
Cadmium
(ug/l)
60 12 0.47(0.38-0.59) 11701 3177
0.34
(0.33-0.35) <0.01
Blood Lead
(ug/dl) 60 0
1.43
(1.17-1.75) 11701 46
1.11
(1.09-1.14) 0.02
Blood Total
Mercury(ug/
l)
60 7 1.04(0.69-1.55) 11701 1588
0.91
(0.86-0.96) 0.50
a LOD: Limit of detection.
b p-value obtained from t-test after accounting for the complex survey design.
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school had higher levels of blood lead compared to those
without HIV infections (all p<0.05).
Table 4 presents the results from multivariate regressions
that showed the difference of blood cadmium, lead and total
mercury according to HIV infection status after adjusting for
age, gender, race/ethnicity, education, PIR, and smoking. The
results from model 1 show that HIV status was significantly
associated with increased blood cadmium. People with HIV
infection have average blood cadmium level 1.16 times
(95%CI: 1.01-1.34) higher those without HIV infection (p=0.03).
However, similar trends were not observed for blood lead and
total mercury between people with and without HIV infection.
Finally, we also did the analyses after additionally adjusting for
the variable of pack-years of smoking, we observed consistent
results. Therefore, we only presented the data from the model
without the variable of pack years.
Table 2. Distribution of demographic and socioeconomic
status by HIV status (n=11,761).
Characteristics HIV (n=60) Non-HIV (n=11,701) p-value
 N
Weighted Percent
(95%CI) N
Weighted Percent
(95%CI)  
Sex (%)      
Male 47 77.05(65.28-88.83) 5530
49.31
(48.40-50.22) <0.01
Female 13 22.95(11.17-34.72) 6171
50.69
(49.78-51.60)  
Age (%)      
18-34 years old 21 28.97(16.18-41.76) 6716
50.37
(48.74-52.00) <0.01
35-49 years old 39 71.03(58.24-83.82) 4985
49.63
(48.00-51.26)  
Race/Ethnicity (%)      
Non-Hispanic
White 9
29.63
(12.80-46.45) 4974
65.39
(61.86-68.92) <0.01
Non-Hispanic
Black 38
49.13
(32.25-66.01) 2529
11.98
(10.18-13.78)  
Hispanic and
others 13 21.24 (7.92-34.57) 4198
22.63
(19.78-25.47)  
Education (%)      
<High school 20 28.66(13.82-43.50) 3170
18.00
(16.64-19.37) 0.17
High school 18 29.35(16.11-42.59) 2921
24.43
(23.05-25.81)  
>High school 22 41.99(25.67-58.32) 5602
57.57
(55.54-59.60)  
PIR (%)      
<1.0 17 24.93(12.26-37.59) 2807
15.85
(14.48-17.22) <0.01
1.0-2.0 17 31.99(15.20-48.78) 2831
19.02
(17.75-20.29)  
≥2.0 20 33.54(19.31-47.78) 5301
59.69
(57.65-61.73)  
Missing 6 9.54 (0.66-18.43) 762 5.44 (4.65-6.24)  
Discussion
The evidence on exposure levels to environmental pollutants
among HIV-infected populations is very limited. In this study,
we found higher body levels of cadmium in persons with HIV.
Even after adjusting for pack-years, HIV infections were still
marginally associated with blood cadmium which may due to
reduced power because of the missing values of pack-years
(16% were missing). The observed result could be caused, in
part, by generally increased prevalence of exposure to poverty
and residing in inner-city areas, which often have higher
exposure to environmental pollutants [31–36]. Another possible
explanation to higher body levels of heavy metals in person
with HIV is that exposures might be similar but HIV infection
may interfere with the body’s ability to clear these toxins
because HIV infection and the use of ART could impair renal
and liver functions, which may lead to impaired detoxification
ability and thus further influence the clearance of heavy metals
in the body [37–39]. Regardless of the mechanisms, our
findings from a nationally representative sample from NHANES
demonstrate a significantly higher level of cadmium in persons
with HIV and suggest that HIV-infected individuals are
potentially at a higher risk of exposure to environmental
pollutants. Therefore, persons with HIV represent an at-risk
group who may benefit from additional screening for exposure,
or intervention strategies to reduce exposure. The findings of
this study were consistent with previous findings. A Russian
study suggests that persons living with HIV may also
extensively be exposed to or accumulate some environmental
pollutants (polychlorinated biphenyls, polycyclic aromatic
hydrocarbons, lead, and mercury) in the bodies [40]. Another
study in different cities of Pakistan also suggested that there
was a significant increase in mean values of arsenic, cadmium,
nickel, and lead in biological samples of AIDS patients as
compared to a controlled healthy male group [41].
The significant difference of heavy metal exposures among
HIV-infected subjects may have important clinical implications.
Although many studies have shown that the higher rates of
noninfectious comorbidities, especially cardiovascular and
respiratory diseases, among HIV-infected patients may be
primarily due to HIV infection and the use of ART [42–46], the
higher exposure to heavy metals suggested in our study may
also play an important role in the development of these chronic
diseases among HIV-infected patients. The associations
between heavy metal exposure and cardiovascular and
respiratory diseases have been suggested by many studies
[19,47–52]. Furthermore, emerging studies showed heavy
metal’s adverse effects on the immune system [53–57].
Therefore, high exposure to these environmental pollutants
may aggravate chronic diseases caused by HIV infection and
the use of ART, or even initiate these diseases among people
with HIV infection. Heavy metal exposure may also help
explain the fact that chronic diseases occur at younger age
group among this population. It is also possible that adverse
effects of these pollutants on immunity may impact the disease
progression of HIV but this has not been assessed in the
current study [58]. Thus, any synergistic effects between heavy
metal exposures and HIV infection remain unknown. Future
Heavy Metals and HIV-Infected Population
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research should address this question and provide evidence to
inform intervention priorities.
Our study has several strengths. The NHANES survey data
provide a unique opportunity to compare the exposure levels to
Table 3. Comparison of Geometric Means of Blood Heavy Metal Concentration by Demographic and Socioeconomic Status
and HIV among US Adults (n=11,761).
 Blood Cadmium (ug/l) Blood Lead (ug/dl) Blood Total Mercury (ug/l)
 HIV Non-HIV  HIV Non-HIV  HIV Non-HIV  
 N
Geometric
Mean(95%CI)a N
Geometric
Mean(95%CI)a
p-
valueb N
Geometric
Mean(95%CI)a N
Geometric
Mean(95%CI)a
p-
valueb N
Geometric
Mean(95%CI)a N
Geometric
Mean(95%CI)a
p-
valueb
Sex
Male 47 0.45(0.35-0.59) 5530
0.32
(0.31-0.33) <0.01 47
1.46
(1.17-1.82) 5530
1.41
(1.37-1.45) 0.74 47
0.93
(0.59-1.47) 5530
0.95
(0.89-1.01) 0.93
Female 13 0.54(0.37-0.80) 6171
0.36
(0.35-0.37) 0.03 13
1.34
(0.91-1.96) 6171
0.88
(0.86-0.91) 0.03 13
1.47
(0.66-3.27) 6171
0.87
(0.83-0.92) 0.19
Age
18-34
Years
Old
21 0.44(0.27-0.71) 6716
0.31
(0.30-0.32) 0.17 21
1.41
(0.99-2.01) 6716
0.97
(0.95-1.00) 0.04 21
0.71
(0.52-0.97) 6716
0.80
(0.75-0.85) 0.47
35-49
Years
Old
39 0.49(0.38-0.64) 4985
0.36
(0.35-0.38) 0.03 39
1.44
(1.15-1.81) 4985
1.28
(1.24-1.32) 0.30 39
1.21
(0.71-2.07) 4985
1.04
(0.98-1.11) 0.57
Race/Ethnicity
Non-
Hispanic
White
9 0.54(0.33-0.86) 4974
0.33
(0.32-0.35) 0.05 9
1.14
(0.87-1.51) 4974
1.06
(1.03-1.09) 0.58 9
0.81
(0.29-2.27) 4974
0.87
(0.81-0.93) 0.90
Non-
Hispanic
Black
38 0.50(0.36-0.71) 2529
0.38
(0.36-0.40) 0.12 38
1.44
(1.11-1.85) 2529
1.17
(1.11-1.24) 0.14 38
0.96
(0.78-1.18) 2529
0.98
(0.91-1.05) 0.85
Hispanic
and
others
13 0.35(0.28-0.44) 4198
0.32
(0.31-0.34) 0.50 13
1.95
(1.57-2.41) 4198
1.26
(1.21-1.31) <0.01 13
1.74
(0.80-3.79) 4198
1.01
(0.94-1.09) 0.16
Education
<High
School 20
0.50
(0.34-0.75) 3170
0.42
(0.40-0.45) 0.39 20
1.51
(1.09-2.08) 3170
1.36
(1.31-1.41) 0.53 20
1.54
(0.69-3.44) 3170
0.71
(0.66-0.77) 0.06
High
School 18
0.53
(0.37-0.76) 2921
0.39
(0.38-0.41) 0.12 18
1.87
(1.32-2.65) 2921
1.18
(1.14-1.23) 0.01 18
1.21
(0.57-2.55) 2921
0.75
(0.70-0.81) 0.19
>High
School 22
0.42
(0.29-0.61) 5602
0.29
(0.29-0.30) 0.06 22
1.15
(0.93-1.41) 5602
1.02
(0.99-1.05) 0.25 22
0.71
(0.47-1.07) 5602
1.06
(1.00-1.13) 0.06
PIR
<1.0 17 0.75(0.49-1.13) 2807
0.43
(0.40-0.46) <0.01 17
2.34
(1.60-3.42) 2807
1.21
(1.15-1.28) <0.01 17
1.00
(0.78-1.28) 2807
0.70
(0.64-0.76) <0.01
1.0-2.0 17 0.41(0.28-0.60) 2831
0.37
(0.35-0.38) 0.51 17
1.10
(0.86-1.42) 2831
1.17
(1.12-1.22) 0.64 17
0.85
(0.42-1.72) 2831
0.79
(0.74-0.86) 0.85
>2.0 20 0.41(0.26-0.64) 5301
0.31
(0.30-0.32) 0.20 20
1.24
(0.96-1.60) 5301
1.06
(1.03-1.09) 0.24 20
1.24
(0.52-2.95) 5301
1.02
(0.96-1.09) 0.65
Missing 6 0.37(0.20-0.70) 762
0.35
(0.33-0.37) 0.82 6
1.59
(0.99-2.57) 762
1.22
(1.16-1.29) 0.27 6
1.16
(0.42-3.20) 762
0.90
(0.77-1.05) 0.62
a Weighted geometric mean with 95% CI
b p-value obtained from t-test after accounting for the complex survey design.
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environmental pollutants among people with and without HIV
infection in a large nationally-representative sample of U.S.
adults. In addition, we were able to adjust for many potential
confounders including demographic status, socioeconomic
status, smoking, and medical condition. Exposure to active and
passive smoking was measured by serum cotinine, which is
generally regarded as the best choice for quantitative
assessment of exposure [27,28,59]. Blood cadmium is reported
to have a half-life of 2.5 months and longer [60], which makes it
a good indicator of recent cadmium exposure. Furthermore, we
also conducted a sensitivity analysis by adjusting for different
combinations of selected confounders in the models to test the
reliability of our estimation. We found consistent results in
these analyses. It suggests that the findings are unlikely
observed by chance.
Several limitations in this study should be considered during
interpretation of our results. First, the NHANES survey
conducted HIV antibody tests mainly to estimate prevalence of
HIV infection in the United States population. However, the
HIV-infected sample in our study was limited and potentially
biased because HIV antibody tests were done only in
participants who agreed to the test. Therefore, those who
already know or are concerned of their HIV status might refuse
and therefore not included in this study. Second, since
measurements of many biomarkers for assessing exposure to
environmental pollutions (i.e. urinary metabolites of polycyclic
aromatic hydrocarbons) were only obtained in a subsample in
NHANES, we can only analyze a few of heavy metals with
enough sample size in this study. Third, the half-life of lead in
human blood is estimated from 28 days to 36 days [61,62],
while the half-life of total mercury is around 5.6 days [63]. In
addition, although serum cotinine is a well-established
biomarker of smoking, its short half-life suggests that it may not
be a good indicator of long-term smoking effects. Therefore,
they can only reflect recent exposure instead of lifetime
exposure if the current exposure sources are greatly different
from the past exposure sources. However, this bias is very
likely to be non-differential, which may bias the estimation
Table 4. Relationship between HIV Status and Log-transformed Blood Heavy Metal Concentrations among US Adults
(n=11,761).
 Blood Cadmium a Blood Lead a Blood Total Mercury a
 Estimate(95% CI) p-value Estimate(95% CI) p-value Estimate(95% CI) p-value
HIV Status
HIV 0.15 (0.01, 0.29) 0.03 -0.05 (-0.23, 0.13) 0.57 0.08 (-0.33, 0.49) 0.69
Non-HIV       
Age
18-34 Years Old       
35-49 Years Old 0.22 (0.19, 0.24) <0.01 0.32 (0.28, 0.35) <0.01 0.24 (0.18, 0.29) <0.01
Sex
Female 0.31 (0.28, 0.33) <0.01 -0.41 (-0.44, -0.39) <0.01 -0.12 (-0.16, -0.07) <0.01
Male       
Race/Ethnicity
Others 0.14 (0.10, 0.18) <0.01 0.20 (0.16, 0.25) <0.01 0.29 (0.20, 0.38) <0.01
Non-Hispanic Black 0.06 (0.02, 0.10) <0.01 0.11 (0.06, 0.16) <0.01 0.24 (0.15, 0.34) <0.01
Non-Hispanic White       
Education
>High School -0.05 (-0.09, -0.01) 0.02 -0.12 (-0.15, -0.08) <0.01 0.35 (0.30, 0.41) <0.01
High School -0.03 (-0.06, 0.02) 0.20 -0.10 (-0.13, -0.06) <0.01 0.07 (0.00, 0.13) 0.05
< High School       
PIR
>2.0 -0.04 (-0.08, 0.01) 0.09 -0.06 (-0.10, -0.02) <0.01 0.26 (0.18, 0.34) <0.01
1.0-2.0 -0.02 (-0.06, 0.02) 0.32 -0.02 (-0.07, 0.02) 0.34 0.07 (0.00, 0.14) 0.05
Missing -0.01 (-0.08, 0.05) 0.67 0.02 (-0.04, 0.08) 0.57 0.16 (0.03, 0.29) 0.02
<1.0       
Serum Cotinine b 0.14 (0.14, 0.15) <0.01 0.04 (0.04, 0.05) <0.01 -0.02 (-0.02, -0.01) <0.01
a Adjusted for age, sex, race/ethnicity, education, PIR, and serum cotinine.
b Concentration of Serum Cotinine was log-transformed.
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toward null. Fourth, active and/or passive smoking may be an
important source of exposure to heavy metals such as
cadmium in the general population [49]. Although we included
serum cotinine as a biomarker of cigarette smoking in the
analysis, this adjustment for cigarette smoking using serum
cotinine may not capture long-term effects of cigarette smoking
on accumulation of cadmium because of given its short half-life
less than a day [64]. Furthermore, although several important
potential confounding factors were included in our study, other
unselected potential confounders such as occupation and diet
may explain some of the difference. Despite limited statistical
power given the small sample size, we have generated
hypotheses that warrant future examination of heavy metals
among HIV infected individuals.
Conclusion
In summary, our study found that HIV-infected patients have
significantly greater exposure to cadmium, compared to those
without HIV infection. Considering the limitations of our study,
further studies and longitudinal data that collect more pollutants
are necessary to determine both the potential increased
exposures of a variety of environmental pollutants and their
synergistic impacts on chronic disease outcomes in HIV-
infected populations. As the life span of HIV-infected patients
will continue to increase due to better treatment methods
available in future and the number of people living with HIV
infection is also expected to be increasing, their exposure to
environmental pollution and its effect on their health should
receive increased public attention.
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